戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              MSLTs were conducted following nocturnal polysomnography
2 lticenter Selective Lymphadenectomy Trial 1 (MSLT-1).
3                                           An MSLT mean sleep latency < or =8 min and > or =2 SOREMPs
4  considered diagnostic without the use of an MSLT; absence of short REML, however, requires a subsequ
5  among OSA patients predict 2omSOREMPs on an MSLT that follows nocturnal polysomnography, we reviewed
6  patients with nocturnal polysomnography and MSLT, including 25 with narcolepsy with cataplexy (N+C),
7 Sensitivity and specificity of NPSG REML and MSLT as diagnostic tests for narcolepsy/hypocretin defic
8 ting characteristic curves for NPSG REML and MSLT findings (sleep studies performed between May 1976
9 n with placebo (27%) (p < 0.01), but not for MSLT (> 10 min; 29% versus 25%).
10 e independent predictors of hypersomnolence (MSLT < 10 min).
11 iple sleep latency test (MSLT) result, or if MSLT is not interpretable, conclusive, or feasible.
12 thickness <1 mm with a Clark level > or =IV (MSLT criterion); LM/SL performed between June 1, 1985, a
13                                 Selection of MSLT patients in the LM/SL/SCLND treatment arm was based
14                          However, a positive MSLT may be found in other sleep disorders, such as beha
15 f short REML, however, requires a subsequent MSLT.
16 tified with the multiple sleep latency test (MSLT) and survival analysis was used to assess the risk
17 nosed using the Multiple Sleep Latency Test (MSLT) following nocturnal polysomnography (NPSG).
18 omSOREMPs) on a Multiple Sleep Latency Test (MSLT) raise the possibility of narcolepsy, patients with
19             The Multiple Sleep Latency Test (MSLT) remains an important diagnostic tool in the diagno
20 t with a normal multiple sleep latency test (MSLT) result, or if MSLT is not interpretable, conclusiv
21 MPs) during the Multiple Sleep Latency Test (MSLT).
22 or a large number of false-positives for the MSLT.
23 on and the incidence of SN metastases in the MSLT and JWCI groups.
24               There were 551 patients in the MSLT group and 584 patients in the JWCI group.
25 ase, the success of SN identification in the MSLT group was independent of the center's case volume o
26  the randomization phase, each center in the MSLT was required to finish a 30-case learning phase wit
27  examined the accuracy of LM/SL/SCLND in the MSLT, using the experience of the organizing center (Joh
28 % CI = 1.9 to 12.7), a 5-min decrease in the MSLT-derived mean sleep latency (OR = 1.9, 95% CI = 1.3
29 ber 30, 1998; and patient not entered in the MSLT.
30 he center's case volume or experience in the MSLT.
31 M) latency during NPSG, were sleepier on the MSLT and reported increased sleepiness, hypnagogic hallu
32  0.001) and in multiple sleep latency times (MSLT) at Week 4 (p < 0.05).
33 Multicenter Selective Lymphadenectomy Trial (MSLT) 5 years ago to evaluate the survival of patients w
34 Multicenter Selective Lymphadenectomy Trial (MSLT-I) to compare 2 treatment approaches: wide excision

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。